Fineline Cube

Follow:
14778 Articles
Company

AbbVie’s Q2 2024 Results Show Resilience Amid Humira Biosimilar Challenges

Company

Roche’s H1’24 Financials Show 5% Growth, Eye Care and Cancer Therapies Drive Sales

Company

AstraZeneca’s Q2 2024 Results Highlight Strong Growth Across Therapies, Excluding Vaccines

CompanyDeals

Amoytop Biotech Opts for NASH Drug Candidate KN069 in Licensing Deal with Alphamab Oncology

CompanyDeals

Oneness Biotech and Microbio Partner with CR Double-Crane for Fespixon Commercialization in China

Company

Sanofi’s Q2 2024 Results Showcase Robust Growth in Pharma and Consumer Health Divisions

CompanyDeals

Agilent Technologies and Shanghai Majorbio Bio-pharm Ink Deal to Transform Life Science Research in China

CompanyDeals

Nanjing Sanhome Pharmaceutical and China Resource Pharma Deepen Collaboration for Market Expansion

CompanyDrug

Jiangsu Suzhong Pharma’s Sutetinib Earns Breakthrough Designation for NSCLC from China’s NMPA

CompanyDeals

Edwards Lifesciences to Acquire Peijia Medical’s US Partner JenaValve, Impact on Licensing Deal Minimal

CompanyDeals

RemeGen Scales Back Private Placement to Fund New Drug R&D

Policy / Regulatory

China’s NMPA Suspends Daewoong Bio’s Antibiotic, Excludes Firm from National Procurement Program